Holen Sie sich die Stockscreener-App
66.60
4.28%
-2.98
Handel nachbörslich:
66.70
0.10
+0.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$69.58
Offen:
$68.895
24-Stunden-Volumen:
10.81M
Relative Volume:
1.14
Marktkapitalisierung:
$81.29B
Einnahmen:
$378.96B
Nettoeinkommen (Verlust:
$5.28B
KGV:
15.89
EPS:
4.19
Netto-Cashflow:
$5.94B
1W Leistung:
+0.35%
1M Leistung:
+4.72%
6M Leistung:
+50.61%
1J Leistung:
+15.79%
1-Tages-Spanne:
$66.54
$69.11
1-Wochen-Bereich:
$66.54
$70.23
52-Wochen-Spanne:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
66.60 | 81.29B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
307.56 | 275.58B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
350.25 | 86.74B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
320.39 | 82.87B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
243.79 | 28.00B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
North Star Investment Management Corp. Has $354,000 Position in CVS Health Corporation (NYSE:CVS) - MarketBeat
Lawsuit says CVS crossed 'ethical and legal line' while fighting late change to pharmacy bill - WBRZ
Class action suit filed against CVS subsidiary for misuse of personal information - KLFY.com
Two Healthcare Heavyweights, One Winner: UnitedHealth or CVS Health? - Yahoo Finance
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025? - The Globe and Mail
Exploring CVS' Health Services Segment: A Key Growth Engine For 2025? - Barchart.com
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth) - AOL.com
CVS Health (CVS) Faces Slight Dip After Recent Gains - GuruFocus
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy? - Yahoo Finance
Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT - Insider Monkey
Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx - Zacks Investment Research
Lesa Sroufe & Co Acquires Shares of 3,965 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Position Reduced by Birch Hill Investment Advisors LLC - MarketBeat
Brown Miller Wealth Management LLC Purchases Shares of 3,784 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Farmers & Merchants Investments Inc. - MarketBeat
15,438 Shares in CVS Health Co. (NYSE:CVS) Purchased by Krilogy Financial LLC - MarketBeat
HIV, AIDS Patients Denied Class Cert. In CVS Bias Fight - Law360
CVS Health stock rises after medicare PBM limits stripped from tax bill - Investing.com
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom - Yahoo Finance
Two Healthcare Heavyweights, One Winner: UnitedHealth Or CVS Health? - Barchart.com
Salem Investment Counselors Inc. Sells 47,415 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Fifth Third Bancorp Has $11.50 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
8,014 Shares in CVS Health Co. (NYSE:CVS) Acquired by Simon Quick Advisors LLC - MarketBeat
Mn Services Vermogensbeheer B.V. Sells 31,000 Shares of CVS Health Corporation (NYSE:CVS) - MarketBeat
Factory Mutual Insurance Co. Has $30.44 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Is the Artificial Intelligence Boost Fading for This Top Tech Stock? - The Motley Fool
CVS Health Co. (NYSE:CVS) Stock Holdings Trimmed by Coerente Capital Management - MarketBeat
Hennessy Advisors Inc. Grows Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health’s SWOT analysis: stock recovery potential amid sector challenges - Investing.com
Louisiana AG investigating CVS for sending mass text messages lobbying against legislation - Providence Business News
CVS Health Stock Sees Relative Strength Rating Rise To 78 - Investor's Business Daily
CVS Health blasts big pharma, praises Trump amid scrutiny of its own drug pricing practicesProvidence Business First - The Business Journals
CVS Wants To Halt Ark. Law Banning PBM-Owned Pharmacies - Law360
CVS Health Co. (NYSE:CVS) Stake Increased by Parkside Investments LLC - MarketBeat
Zacks.com featured highlights include Flex, CVS Health, Urban Outfitters and Exelixis - Yahoo Finance
Avanza Fonder AB Has $6.22 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
KMG Fiduciary Partners LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Seeks Court-Ordered Pause on Embattled Arkansas Pharmacy Law - Bloomberg Law News
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends? - Barchart.com
CVS Health Co. (NYSE:CVS) Shares Bought by Toth Financial Advisory Corp - MarketBeat
Is CVS Health Stock Outperforming the Nasdaq? - MSN
CVS vs. DHR: Which Stock Should Value Investors Buy Now? - Yahoo Finance
SG Americas Securities LLC Acquires 174,606 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Feds seek $706 million in penalties from Omnicare, CVS in False Claims Act case - McKnight's Senior Living
CVS Health: Seems Primed To Withstand Industry Woes (NYSE:CVS) - Seeking Alpha
CVS Settles Cigna Lawsuit Over Ex-Executive’s Noncompete Pact - Bloomberg Law News
CVS retains some liability in Omnicare false claims suit, federal judge says - McKnight's Senior Living
CVS Health Co. (NYSE:CVS) Shares Sold by Wesbanco Bank Inc. - MarketBeat
Government Seeks $706M Penalty in FCA Case Against Omnicare and CVS Health - USA Herald
Naples Global Advisors LLC Lowers Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvs Health Corp-Aktie (CVS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 02 '25 |
Sale |
67.86 |
2,276,068 |
154,444,758 |
9,670,731 |
| ROBBINS LARRY | Director |
May 05 '25 |
Sale |
67.41 |
1,323,932 |
89,249,945 |
8,346,799 |
| ROBBINS LARRY | Director |
May 06 '25 |
Sale |
66.67 |
150,000 |
10,000,710 |
8,196,799 |
| Shah Prem S | EVP and Group President |
Mar 17 '25 |
Option Exercise |
62.21 |
846 |
52,630 |
43,190 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Option Exercise |
62.21 |
7,513 |
467,384 |
15,907 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Sale |
66.35 |
7,513 |
498,488 |
8,394 |
4.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):